Suppliers / Bespak Hc

Bespak Hc

United Kingdom Updated 9 July 2026

Bespak Hc is a finished-dose manufacturer based in United Kingdom. It appears in 3 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with INVIMA (CO), ARCSA (EC) and EDE (AE). Its GMP standing is certified by MHRA (UK), MFDS (Korea) and ANVISA (Brazil), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 26 November 2020 as VAI.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
3
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 26 November 2020 VAI US FDA
  • 10 November 2017 VAI US FDA
  • 15 January 2016 VAI US FDA
  • 7 March 2014 NAI US FDA
  • 9 September 2011 VAI US FDA
  • 28 August 2009 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Holmes Chapel, United Arab Emirates Not on file
CREWE, United Kingdom Not on file
United Kingdom, United Kingdom 3001621739

Filings and GMP by regulator

Regulator Filings GMP certificates
INVIMA (CO) 1 None
ARCSA (EC) 1 None
EDE (AE) 1 None
MHRA (UK) None 4
MFDS (Korea) None 2
ANVISA (Brazil) None 2
NCELS (KZ) None 1

Comparing suppliers?

Choose your molecules and target markets. Bespak Hc comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 26 November 2020.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates